GCP
BIOR

GSA Capital Partners’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

GSA Capital Partners’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,842
Closed -$148K – 2057
2023
Q2 		$148K Sell
3,842
-1,908
-33% -$67.3K 0.01% 1343
2023
Q1 		$159K Sell
5,750
-2,608
-31% -$88.4K 0.02% 1300
2022
Q4 		$275K Buy
8,358
+5,109
+157% +$373K 0.03% 994
2022
Q3 		$394K Buy
+3,249
New +$585K 0.05% 754
2022
Q1 		– Sell
-207
Closed -$108K – 1964
2021
Q4 		$108K Sell
207
-2,253
-92% -$1.62M 0.01% 1309
2021
Q3 		$935K Buy
+2,460
New +$1.05M 0.1% 336

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

GSA Capital Partners's BIOR Position: Q3 2023 in Review

GSA Capital Partners sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2023, closing a stake of 3,842 shares — an estimated $148K sold.

GSA Capital Partners first reported a position in BIOR in Q3 2021 and held it in 6 quarters. The position peaked at $935K in Q3 2021. 24 funds tracked by Wall St. Rank hold BIOR as of Q3 2023.

  • GSA Capital Partners reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 3,842 Biora Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $148K.
  • GSA Capital Partners first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • GSA Capital Partners's Biora Therapeutics, Inc. Common Stock position peaked at $935K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.